Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF101 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLFN11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASGEF1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADPRM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFE2L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB7B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCEAL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHLDB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR3C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BVES - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARD6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAV3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on